Talphera
Presence
Talphera is a company listed under the stock ticker ACRX (US).
Executives
View the org chart displaying its 9 main executives
Most searched biographies at Talphera
- Vincent Angotti, Chief Executive Officer and Director
- Adrian Adams, Chairman of the Board
- Marina Bozilenko, Independent Director
Popular executive movements at Talphera
- Howard Rosen, Board Member, has left the company (posted on March 4 2024).
- Richard Afable, Director, has left the company (posted on March 4 2024).
Create your alert
to follow the executive moves at Talphera.
Pharmaceuticals
Talphera has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Talphera
- AcelRx to Host Third Quarter 2020 Financial Results Call and Webcast on Thursday, November 5, 2020 | AcelRx Pharmaceuticals, Inc.
- AcelRx to Host Virtual KOL Event on Perioperative Use of DSUVIA® | AcelRx Pharmaceuticals, Inc.
- AcelRx Awarded U.S. Army Contract for DSUVIA® | AcelRx Pharmaceuticals, Inc.
- AcelRx Announces DSUVIA® Added to the U.S. Department of Defense's Joint Deployment Formulary | AcelRx Pharmaceuticals, Inc.
- AcelRx Pharmaceuticals to Present at Two Upcoming Conferences | AcelRx Pharmaceuticals, Inc.
- AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Orthopedic Patients in the Perioperative Setting | AcelRx Pharmaceuticals, Inc.
- AcelRx Pharmaceuticals Announces Publication of Clinical Data on Reduced Opioid Use and Reduced Time in the Postanesthesia Care Unit (PACU) Following Preoperative Administration of DSUVIA® | AcelRx Pharmaceuticals, Inc.
- AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results | AcelRx Pharmaceuticals, Inc.
- AcelRx to Host Second Quarter 2020 Financial Results Call and Webcast on Monday, August 10th, 2020 | AcelRx Pharmaceuticals, Inc.
- AcelRx Announces Exclusive Distribution and Promotion Partnership for DSUVIA® | AcelRx Pharmaceuticals, Inc.
- View more press releases Close
Social media about Talphera
- Talphera on Wikipedia, Google News & Yahoo Finance
- Talphera on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Vincent Angotti 
